News OptimizeRx Corporation

Equities

OPRX

US68401U2042

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
10.12 ^USD	+15.00%		+8.58%	-29.28%

Apr. 16	Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q4 Revenue $28.4M	MT
Apr. 16	Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q4 EPS $0.26	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET	Apr. 26	AQ
OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report	Apr. 18	AQ
Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q4 Revenue $28.4M	Apr. 16	MT
Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q4 EPS $0.26	Apr. 16	MT
OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results	Apr. 16	AQ
OptimizeRx Corporation Reiterates Financial Guidance for the Full Year 2024	Apr. 16	CI
OptimizeRx Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 15	CI
OptimizeRx : ESG Report	Apr. 11	PU
OptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a Row	Apr. 11	AQ
OptimizeRx : Corporate Presentation	Apr. 05	PU
JMP Securities Initiates Coverage on OptimizeRx With Market Perform Rating, $15 Price Target	Apr. 04	MT
OptimizeRx Expected to Meet 2024 Guidance, RBC Says; Shares Drop	Apr. 01	MT
Transcript : OptimizeRx Corporation, Q4 2023 Earnings Call, Mar 28, 2024	Mar. 28
Tranche Update on OptimizeRx Corporation's Equity Buyback Plan announced on March 14, 2023.	Mar. 27	CI
OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET	Mar. 25	AQ
OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023	Mar. 11	AQ
OptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community’ Outreach Effort	Mar. 04	AQ
OptimizeRx Corp. Powers Walmart's ?Specialty Pharmacies of the Community? Outreach Effort	Mar. 04	CI
OptimizeRx to Participate in Upcoming Investor Conferences	Feb. 21	AQ
OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape	Jan. 25	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News OptimizeRx Corporation

Equities

OPRX

US68401U2042

Summary

Filters